Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Disruption of proteostatic networks in Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
David R Borchelt and Guilian Xu
J Alzheimers Dis Parkinsonism
DOI:
Atsushi Nagai, Abdullah Md Sheikh, Shatera Tabassum, Shozo Yano, Takafumi Ikeue, Makoto Handa
J Alzheimers Dis Parkinsonism
DOI:
Ji Zhong Bai and Janusz Lipski
Common risk factors for Alzheimer�s disease and vascular dementia
J Alzheimers Dis Parkinsonism
DOI:
Ken Nagata, Takashi Yamazaki and Daiki Takano
J Alzheimers Dis Parkinsonism
DOI:
Rosanna Squitti
Body mass index and risk of future dementia over two decades in two million people
J Alzheimers Dis Parkinsonism
DOI:
Qizilbash Nawab, Gregson J, Johnson M, Pearce N, Douglas I, Wing K, Evans S J W and Pocock S
Traumatic Brain Injury (TBI) as a missed cause of Dementia
J Alzheimers Dis Parkinsonism
DOI:
Anne Felicia Ambrose
Addressing nutritional requirements in early Alzheimer�s disease: What, why and when?
J Alzheimers Dis Parkinsonism
DOI:
Laus Broersen
J Alzheimers Dis Parkinsonism
DOI:
Piotr Lewczuk
Altered copper metabolism as a theranostic biomarker in neurodegeneration
J Alzheimers Dis Parkinsonism
DOI:
Fangyu Peng
The Aβ oligomer count in CSF is a useful biomarker for Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Dieter Willbold
J Alzheimers Dis Parkinsonism
DOI:
Fabrizio Piazza, S M Greenberg, A Lleo Bisa, J F Vazquez Costa, R Nitrini, A Kakita, Y Hagiwara, G Giaccone, G Boncoraglio, M Glatzel, C Marini1, A Uncini, S Cirillo, F Tagliavini, C Ferrarese and J C DiFrancesco
J Alzheimers Dis Parkinsonism
DOI:
Shigeru Sase
PZP: A novel biomarker for early Alzheimer�s disease?
J Alzheimers Dis Parkinsonism
DOI:
Diana A T Nijholt
Unexpected brain MRI abnormalities in aging research studies
J Alzheimers Dis Parkinsonism
DOI:
Howard A Rowley
Tau PET imaging: New insight into early diagnosis of tauopathy
J Alzheimers Dis Parkinsonism
DOI:
Naruhiko Sahara
Early dysfunctions preceding neurodegeneration in synucleinopathy
J Alzheimers Dis Parkinsonism
DOI:
Elvira De Leonibus
Alzheimer disease and neuroplasticity: New approaches and new targets
J Alzheimers Dis Parkinsonism
DOI:
Tayfun Uzbay
J Alzheimers Dis Parkinsonism
DOI:
Filippo Caraci
Stealth adapted viruses, alternative cellular energy (ACE) pathway and Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
W John Martin
The role of apoptotic mechanisms in the pathophysiology of Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Rona K Graham
J Alzheimers Dis Parkinsonism
DOI:
James A Duce
P53 family pathway activation in microglia; implications for neurodegeneration
J Alzheimers Dis Parkinsonism
DOI:
Jennifer Pocock
Optogenetic investigation of brain network dysfunction in Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Mondragon-Rodriguez Siddhartha
J Alzheimers Dis Parkinsonism
DOI:
Calsolaro Valeria, Pasqualetti Giuseppe, Tognini Sara, Polini Antonio, Cottone Silvia, Bini Giacomo1, Atteo Elisabetta, De Feo Paola1, Meucci Giuseppe and Monzani Fabio
A prophylactic daily program for dementia
J Alzheimers Dis Parkinsonism
DOI:
Toru Itakura and Yoshihito Owai
J Alzheimers Dis Parkinsonism
DOI:
Hansotto Reiber, Peter Lange and Inga Zerr
Genetic modifiers of repeat expansions in C9ORF72
J Alzheimers Dis Parkinsonism
DOI:
Markavan Blitterswijk
Dementia in children and young adults with Niemann-Pick disease type C (NPC)
J Alzheimers Dis Parkinsonism
DOI:
Jacqueline Imrie
Managing mood and behaviors in long-term care facilities in the United States
J Alzheimers Dis Parkinsonism
DOI:
Eric G Tangalos
J Alzheimers Dis Parkinsonism
DOI:
Sanjay Asthana, Carey Gleason, Maritza Dowling and Whitney Wharton
J Alzheimers Dis Parkinsonism
DOI:
Eef Hogervorst
Vitamin B12 deficiency and cognitive impairment: Re-visiting an old acquaintance
J Alzheimers Dis Parkinsonism
DOI:
Belinda Vicioso
Indicators of quality of care for patients with dementia in the acute care setting
J Alzheimers Dis Parkinsonism
DOI:
Melinda Martin Khan
J Alzheimers Dis Parkinsonism
DOI:
Attila Lawrence
Latent Herpes virus infection cognitive deterioration and dementia
J Alzheimers Dis Parkinsonism
DOI:
Federico Licastro
Long-term ongoing structured support in early stage of dementia: PER-model
J Alzheimers Dis Parkinsonism
DOI:
Annika Kjallman Alm
Black and minority ethnic communities and dementia: Where are we now?
J Alzheimers Dis Parkinsonism
DOI:
Truswell David
Dementia and public health: Promise, pitfalls and progress
J Alzheimers Dis Parkinsonism
DOI:
Melinda Martin Khan, Travers C, Halliday L and Lie D
J Alzheimers Dis Parkinsonism
DOI:
Neli Petrova, S Mehrabian, M Raycheva and L Traykov
What are the prospects of slowing the progression of Alzheimer�s disease?
J Alzheimers Dis Parkinsonism
DOI:
Alan M Palmer
J Alzheimers Dis Parkinsonism
DOI:
Barbara C Fisher
Amylin: What might be its role in Alzheimer�s disease and how could this affect therapy?
J Alzheimers Dis Parkinsonism
DOI:
Charles De Carli
J Alzheimers Dis Parkinsonism
DOI:
Florindo Stella
Insulin-like growth factor II reverses memory and synaptic impairments in APP transgenic mice
J Alzheimers Dis Parkinsonism
DOI:
Ana Gracia Osta, Garcia-Barroso C, Ugarte A, Oyarazabal J and Mar Cuadrado-Tejedor
Epigenetic approaches for the treatment of Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Mar Cuadrado-Tejedor, Carolina Garcia-Barroso, Julen Oyarzabal and Ana Garcia-Osta
J Alzheimers Dis Parkinsonism
DOI:
Lydia Gimenez Llort
J Alzheimers Dis Parkinsonism
DOI:
John A Schetz
J Alzheimers Dis Parkinsonism
DOI:
Laura Morelli
New cellular models for drug discovery in Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Jordan L Holtzman
Involvement of PKR in Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
Jacques Hugon, Julien Dumurgier, Fran�ois Mouton-Liger, Pauline Lapalus, Magali Prevot, Sandrine Indart, Jean Louis Laplanche and Claire Paquet
Development of polysorbate-80 coated galantamine nanorticles to treat Alzheimer�s disease
J Alzheimers Dis Parkinsonism
DOI:
C Vijaya Raghavan, N Tamilselvan, K Balakumar, Siram Karthik
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals